Searched for
SEIZURE TREATMENT DRUG
Drug counselor who delivered 'Friends' star Matthew Perry ketamine that killed him gets 2 yearsErik Fleming, a drug counselor, received a two-year prison sentence. He supplied Matthew Perry with ketamine that led to the actor's death....- Fake life-saving medicine racket busted in Delhi: Here's how they repackaged and sold drugs across several statesDelhi Police crime branch busted an interstate counterfeit medicine racket, arresting four individuals. The network allegedly sourced gover...
- Alembic Pharma gets USFDA nod for generic drugAlembic Pharmaceuticals has secured approval from the US health regulator for a generic seizure medication. The company received final clea...
- USFDA approves Glenmark Pharma's seizure treatment drugNew Delhi-based Glenmark's USFDA-approved 15 mg and 25 mg Topiramate capsules, equivalent to Janssen's Topamax, will be marketed by Glenmar...
- Cipla unit recalls one lot of medication in US due to seal integrity issueDrug major Cipla's subsidiary is voluntarily recalling one lot of medication in the US due to seal integrity issues. InvaGen Pharmaceutical...
- Sun Pharmaceutical launches phenobarbital sodium injection in US"The launch of SEZABY is an exciting addition to our growing portfolio of specialty branded products in the US," Sun Pharma CEO North Ameri...
- A high-fat low-carb diet coupled with the right meds can curb seizures: StudyThe right lifestyle can prevent fits to a large extent.
- Sun Pharma gets USFDA nod for drug to treat neonatal seizures"With this approval, SEZABY becomes the first and only product specifically indicated in the US for the treatment of neonatal seizures in t...
- Sun Pharma inks licensing pact with SPARC to commercialise medication in US marketSPARC submitted a new drug application (NDA) to the US Food and Drug Administration (US FDA) for the said product in February 2022.
- Zydus gets final US FDA nod to market generic version of Vigabatrin tabletsCadila Healthcare Ltd on Thursday said group firm Zydus has received final approval from the US health regulator to market its generic vers...
- Glenmark Pharma gets USFDA nod for seizure treatment drugGlenmark Pharmaceuticals Ltd has received final approval from the United States Food and Drug Administration (USFDA) for Topiramate extende...
- Unichem Labs gets USFDA nod to market generic capsulesThe company has received abbreviated new drug application (ANDA) approval to market its Zonisamide capsules, USP 25 mg, 50 mg and 100 mg fr...
- Alembic Pharma gets USFDA nod for seizure treatment drugThe approved product is therapeutically equivalent to the reference listed drug Klonopin orally disintegrating tablets of Hoffmann-La Roche...
- Lupin launches generic seizure drug in USThe company has launched Clobazam tablets in the strengths of 10 mg and 20 mg, after having received an approval from the United States Foo...
- Good news for epileptic patients: Implanting new device in brain can prevent seizuresThe researchers used a neurotransmitter which acts as the 'brake' at the source.
- Planned pregnancy can help 90% epileptic women have healthy babiesNew Delhi, Nov 19 (IANS) Planned pregnancy can help 90 per cent of epileptic women deliver healthy babies, said doctors.
- FDA approves first 3D-printed drugIn a world first, the US has approved a 3D-printed drug to treat certain types of seizures in epilepsy patients.
- Aurobindo Pharma gets tentative nod from USFDA for Lacosamide tabletsThis ANDA is at present under litigation in the United States District Court for the District of Delaware, Aurobindo Pharma said.
- SPARC gets USFDA nod for its anti-epileptic drug ELEPSIA XR"Approval of ELEPSIA XRTM as 1,000 mg and 1,500 mg once a day tablets will be very useful for these patients and physicians."
- SPARC developing drugs for allergies, inflammation & seizuresSPARC has said it is developing new drugs for allergies, inflammations, neuropathy and seizures under its drug discovery programme.
Load More
